Wound of the Oral Cavity

DrugDrug NameDrug Description
DB10771Bovine type I collagenA collagen gel derived from cows used to treat a wide variety of wounds, as well as a supplement for bones and joints.
DB10770Foreskin fibroblast (neonatal)A treatment of cells used to treat full-thickness, diabetic foot ulcers that extend through the dermis without tendon, muscle, joint capsule, or bone exposure.
DB10772Foreskin keratinocyte (neonatal)A treatment of skin cells used to accelerate wound closure and healing.
DrugDrug NameTargetType
DB10770Foreskin fibroblast (neonatal)Interleukin-6target
DB10770Foreskin fibroblast (neonatal)Vascular endothelial growth factor receptor 1target
DB10770Foreskin fibroblast (neonatal)Interleukin-1 receptor type 1target
DB10770Foreskin fibroblast (neonatal)TGF-beta receptor type-2target
DB10770Foreskin fibroblast (neonatal)Fibroblast growth factor 1target
DB10770Foreskin fibroblast (neonatal)Interferon gammatarget
DB10770Foreskin fibroblast (neonatal)Fibroblast growth factor receptor 2target
DB10770Foreskin fibroblast (neonatal)Granulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
DB10770Foreskin fibroblast (neonatal)Platelet-derived growth factor receptor betatarget
DB10770Foreskin fibroblast (neonatal)Transforming growth factor beta-1target
DB10770Foreskin fibroblast (neonatal)Tumor necrosis factortarget
DB10772Foreskin keratinocyte (neonatal)Fibroblast growth factor 1target
DB10772Foreskin keratinocyte (neonatal)Epidermal growth factor receptortarget
DB10772Foreskin keratinocyte (neonatal)Granulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
DB10772Foreskin keratinocyte (neonatal)Interleukin-1 betatarget
DB10772Foreskin keratinocyte (neonatal)Interleukin-6target
DB10772Foreskin keratinocyte (neonatal)Interferon gammatarget
DB10772Foreskin keratinocyte (neonatal)Fibroblast growth factor receptor 2target
DB10772Foreskin keratinocyte (neonatal)Platelet-derived growth factor receptor alphatarget
DB10772Foreskin keratinocyte (neonatal)TGF-beta receptor type-2target
DB10772Foreskin keratinocyte (neonatal)Transforming growth factor beta-1target
DB10772Foreskin keratinocyte (neonatal)Tumor necrosis factortarget
DB10772Foreskin keratinocyte (neonatal)Vascular endothelial growth factor Atarget
DrugDrug NamePhaseStatusCount